Global Pseudorabies Virus Vaccine Market Research Report 2025(Status and Outlook)
Pseudorabies virus vaccines are biological preparations designed to immunize swine against Aujeszky's disease, a highly contagious viral infection caused by suid herpesvirus 1 (SHV-1) that affects the nervous and respiratory systems of pigs, leading to significant economic losses in the global pork industry; these vaccines are primarily based on modified live virus (MLV), inactivated (killed), or gene-deleted (marker) strains, with the latter enabling differentiation between infected and vaccinated animals (DIVA strategy) to support eradication programs and international trade compliance.
The global Pseudorabies Virus Vaccine market size was estimated at USD 312.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pseudorabies Virus Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pseudorabies Virus Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pseudorabies Virus Vaccine market.
Global Pseudorabies Virus Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Merial Limited
Boehringer Ingelheim Animal Health (USA) Co.Ltd.
Zoetis
Hipra
Anhui Divinity Biological Products
Wuhan Keqian Biological Co.Ltd.
China Biotechnology Co.Ltd.
CHINA ANIMAL HUSBANDRY INDUSTRY
Sichuan Huashen
Haley
Tianbang
Dabei Nong
Harvey
Preh Bio
Jiangsu Nannong High-Tech Co.
Guangxi Liyuan Biological Co.Ltd.
Jilin Zhengye Bioengineering Group
Jilin Heyuan Biological Engineering Co.Ltd.
Huapai Biological Engineering Group Co.Ltd.
Beijing Xinde Weite Technology Co.Ltd.
Beijing Veterinary Biopharmaceutical Factory
Qilu Animal Health Products Co.Ltd.
Shanxi Longkel Bio-Pharmaceutical Co.Ltd.
Yunnan Biopharmaceutical Co.
Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd.
Liaoning Yikang Biological Co.Ltd.
Shanghui Huahong Biological Engineering Co.Ltd.
Sichuan Hailinge Biological Pharmaceutical Co.Ltd.
Guangdong Yongshun Biological Pharmaceutical Co.Ltd.
Market Segmentation (by Type)
Inactivated Vaccine
Naturally Deficient Attenuated Vaccine
Genetic Engineering Vaccine
Market Segmentation (by Application)
Government Tender
Market Sales
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pseudorabies Virus Vaccine Market
Overview of the regional outlook of the Pseudorabies Virus Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pseudorabies Virus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pseudorabies Virus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pseudorabies Virus Vaccine market size was estimated at USD 312.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pseudorabies Virus Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pseudorabies Virus Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pseudorabies Virus Vaccine market.
Global Pseudorabies Virus Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Merial Limited
Boehringer Ingelheim Animal Health (USA) Co.Ltd.
Zoetis
Hipra
Anhui Divinity Biological Products
Wuhan Keqian Biological Co.Ltd.
China Biotechnology Co.Ltd.
CHINA ANIMAL HUSBANDRY INDUSTRY
Sichuan Huashen
Haley
Tianbang
Dabei Nong
Harvey
Preh Bio
Jiangsu Nannong High-Tech Co.
Guangxi Liyuan Biological Co.Ltd.
Jilin Zhengye Bioengineering Group
Jilin Heyuan Biological Engineering Co.Ltd.
Huapai Biological Engineering Group Co.Ltd.
Beijing Xinde Weite Technology Co.Ltd.
Beijing Veterinary Biopharmaceutical Factory
Qilu Animal Health Products Co.Ltd.
Shanxi Longkel Bio-Pharmaceutical Co.Ltd.
Yunnan Biopharmaceutical Co.
Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd.
Liaoning Yikang Biological Co.Ltd.
Shanghui Huahong Biological Engineering Co.Ltd.
Sichuan Hailinge Biological Pharmaceutical Co.Ltd.
Guangdong Yongshun Biological Pharmaceutical Co.Ltd.
Market Segmentation (by Type)
Inactivated Vaccine
Naturally Deficient Attenuated Vaccine
Genetic Engineering Vaccine
Market Segmentation (by Application)
Government Tender
Market Sales
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pseudorabies Virus Vaccine Market
Overview of the regional outlook of the Pseudorabies Virus Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pseudorabies Virus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pseudorabies Virus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pseudorabies Virus Vaccine
1.2 Key Market Segments
1.2.1 Pseudorabies Virus Vaccine Segment by Type
1.2.2 Pseudorabies Virus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PSEUDORABIES VIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pseudorabies Virus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Pseudorabies Virus Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PSEUDORABIES VIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pseudorabies Virus Vaccine Product Life Cycle
3.3 Global Pseudorabies Virus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pseudorabies Virus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pseudorabies Virus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pseudorabies Virus Vaccine Market Competitive Situation and Trends
3.8.1 Pseudorabies Virus Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pseudorabies Virus Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PSEUDORABIES VIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pseudorabies Virus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PSEUDORABIES VIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pseudorabies Virus Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pseudorabies Virus Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PSEUDORABIES VIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pseudorabies Virus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pseudorabies Virus Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Pseudorabies Virus Vaccine Price by Type (2020-2025)
7 PSEUDORABIES VIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pseudorabies Virus Vaccine Market Sales by Application (2020-2025)
7.3 Global Pseudorabies Virus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pseudorabies Virus Vaccine Sales Growth Rate by Application (2020-2025)
8 PSEUDORABIES VIRUS VACCINE MARKET SALES BY REGION
8.1 Global Pseudorabies Virus Vaccine Sales by Region
8.1.1 Global Pseudorabies Virus Vaccine Sales by Region
8.1.2 Global Pseudorabies Virus Vaccine Sales Market Share by Region
8.2 Global Pseudorabies Virus Vaccine Market Size by Region
8.2.1 Global Pseudorabies Virus Vaccine Market Size by Region
8.2.2 Global Pseudorabies Virus Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Pseudorabies Virus Vaccine Sales by Country
8.3.2 North America Pseudorabies Virus Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pseudorabies Virus Vaccine Sales by Country
8.4.2 Europe Pseudorabies Virus Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pseudorabies Virus Vaccine Sales by Region
8.5.2 Asia Pacific Pseudorabies Virus Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pseudorabies Virus Vaccine Sales by Country
8.6.2 South America Pseudorabies Virus Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pseudorabies Virus Vaccine Sales by Region
8.7.2 Middle East and Africa Pseudorabies Virus Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PSEUDORABIES VIRUS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pseudorabies Virus Vaccine by Region(2020-2025)
9.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pseudorabies Virus Vaccine Production
9.4.1 North America Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pseudorabies Virus Vaccine Production
9.5.1 Europe Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pseudorabies Virus Vaccine Production (2020-2025)
9.6.1 Japan Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pseudorabies Virus Vaccine Production (2020-2025)
9.7.1 China Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Pseudorabies Virus Vaccine Product Overview
10.1.3 Merck Pseudorabies Virus Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Merial Limited
10.2.1 Merial Limited Basic Information
10.2.2 Merial Limited Pseudorabies Virus Vaccine Product Overview
10.2.3 Merial Limited Pseudorabies Virus Vaccine Product Market Performance
10.2.4 Merial Limited Business Overview
10.2.5 Merial Limited SWOT Analysis
10.2.6 Merial Limited Recent Developments
10.3 Boehringer Ingelheim Animal Health (USA) Co.Ltd.
10.3.1 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Basic Information
10.3.2 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.3.3 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.3.4 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Business Overview
10.3.5 Boehringer Ingelheim Animal Health (USA) Co.Ltd. SWOT Analysis
10.3.6 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Recent Developments
10.4 Zoetis
10.4.1 Zoetis Basic Information
10.4.2 Zoetis Pseudorabies Virus Vaccine Product Overview
10.4.3 Zoetis Pseudorabies Virus Vaccine Product Market Performance
10.4.4 Zoetis Business Overview
10.4.5 Zoetis Recent Developments
10.5 Hipra
10.5.1 Hipra Basic Information
10.5.2 Hipra Pseudorabies Virus Vaccine Product Overview
10.5.3 Hipra Pseudorabies Virus Vaccine Product Market Performance
10.5.4 Hipra Business Overview
10.5.5 Hipra Recent Developments
10.6 Anhui Divinity Biological Products
10.6.1 Anhui Divinity Biological Products Basic Information
10.6.2 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Overview
10.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Market Performance
10.6.4 Anhui Divinity Biological Products Business Overview
10.6.5 Anhui Divinity Biological Products Recent Developments
10.7 Wuhan Keqian Biological Co.Ltd.
10.7.1 Wuhan Keqian Biological Co.Ltd. Basic Information
10.7.2 Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.7.3 Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.7.4 Wuhan Keqian Biological Co.Ltd. Business Overview
10.7.5 Wuhan Keqian Biological Co.Ltd. Recent Developments
10.8 China Biotechnology Co.Ltd.
10.8.1 China Biotechnology Co.Ltd. Basic Information
10.8.2 China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.8.3 China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.8.4 China Biotechnology Co.Ltd. Business Overview
10.8.5 China Biotechnology Co.Ltd. Recent Developments
10.9 CHINA ANIMAL HUSBANDRY INDUSTRY
10.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Basic Information
10.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Overview
10.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Market Performance
10.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Business Overview
10.9.5 CHINA ANIMAL HUSBANDRY INDUSTRY Recent Developments
10.10 Sichuan Huashen
10.10.1 Sichuan Huashen Basic Information
10.10.2 Sichuan Huashen Pseudorabies Virus Vaccine Product Overview
10.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Product Market Performance
10.10.4 Sichuan Huashen Business Overview
10.10.5 Sichuan Huashen Recent Developments
10.11 Haley
10.11.1 Haley Basic Information
10.11.2 Haley Pseudorabies Virus Vaccine Product Overview
10.11.3 Haley Pseudorabies Virus Vaccine Product Market Performance
10.11.4 Haley Business Overview
10.11.5 Haley Recent Developments
10.12 Tianbang
10.12.1 Tianbang Basic Information
10.12.2 Tianbang Pseudorabies Virus Vaccine Product Overview
10.12.3 Tianbang Pseudorabies Virus Vaccine Product Market Performance
10.12.4 Tianbang Business Overview
10.12.5 Tianbang Recent Developments
10.13 Dabei Nong
10.13.1 Dabei Nong Basic Information
10.13.2 Dabei Nong Pseudorabies Virus Vaccine Product Overview
10.13.3 Dabei Nong Pseudorabies Virus Vaccine Product Market Performance
10.13.4 Dabei Nong Business Overview
10.13.5 Dabei Nong Recent Developments
10.14 Harvey
10.14.1 Harvey Basic Information
10.14.2 Harvey Pseudorabies Virus Vaccine Product Overview
10.14.3 Harvey Pseudorabies Virus Vaccine Product Market Performance
10.14.4 Harvey Business Overview
10.14.5 Harvey Recent Developments
10.15 Preh Bio
10.15.1 Preh Bio Basic Information
10.15.2 Preh Bio Pseudorabies Virus Vaccine Product Overview
10.15.3 Preh Bio Pseudorabies Virus Vaccine Product Market Performance
10.15.4 Preh Bio Business Overview
10.15.5 Preh Bio Recent Developments
10.16 Jiangsu Nannong High-Tech Co.
10.16.1 Jiangsu Nannong High-Tech Co. Basic Information
10.16.2 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Overview
10.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Market Performance
10.16.4 Jiangsu Nannong High-Tech Co. Business Overview
10.16.5 Jiangsu Nannong High-Tech Co. Recent Developments
10.17 Guangxi Liyuan Biological Co.Ltd.
10.17.1 Guangxi Liyuan Biological Co.Ltd. Basic Information
10.17.2 Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.17.3 Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.17.4 Guangxi Liyuan Biological Co.Ltd. Business Overview
10.17.5 Guangxi Liyuan Biological Co.Ltd. Recent Developments
10.18 Jilin Zhengye Bioengineering Group
10.18.1 Jilin Zhengye Bioengineering Group Basic Information
10.18.2 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Overview
10.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Market Performance
10.18.4 Jilin Zhengye Bioengineering Group Business Overview
10.18.5 Jilin Zhengye Bioengineering Group Recent Developments
10.19 Jilin Heyuan Biological Engineering Co.Ltd.
10.19.1 Jilin Heyuan Biological Engineering Co.Ltd. Basic Information
10.19.2 Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.19.3 Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.19.4 Jilin Heyuan Biological Engineering Co.Ltd. Business Overview
10.19.5 Jilin Heyuan Biological Engineering Co.Ltd. Recent Developments
10.20 Huapai Biological Engineering Group Co.Ltd.
10.20.1 Huapai Biological Engineering Group Co.Ltd. Basic Information
10.20.2 Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.20.3 Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.20.4 Huapai Biological Engineering Group Co.Ltd. Business Overview
10.20.5 Huapai Biological Engineering Group Co.Ltd. Recent Developments
10.21 Beijing Xinde Weite Technology Co.Ltd.
10.21.1 Beijing Xinde Weite Technology Co.Ltd. Basic Information
10.21.2 Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.21.3 Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.21.4 Beijing Xinde Weite Technology Co.Ltd. Business Overview
10.21.5 Beijing Xinde Weite Technology Co.Ltd. Recent Developments
10.22 Beijing Veterinary Biopharmaceutical Factory
10.22.1 Beijing Veterinary Biopharmaceutical Factory Basic Information
10.22.2 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Overview
10.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Market Performance
10.22.4 Beijing Veterinary Biopharmaceutical Factory Business Overview
10.22.5 Beijing Veterinary Biopharmaceutical Factory Recent Developments
10.23 Qilu Animal Health Products Co.Ltd.
10.23.1 Qilu Animal Health Products Co.Ltd. Basic Information
10.23.2 Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.23.3 Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.23.4 Qilu Animal Health Products Co.Ltd. Business Overview
10.23.5 Qilu Animal Health Products Co.Ltd. Recent Developments
10.24 Shanxi Longkel Bio-Pharmaceutical Co.Ltd.
10.24.1 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Basic Information
10.24.2 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.24.3 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.24.4 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Business Overview
10.24.5 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Recent Developments
10.25 Yunnan Biopharmaceutical Co.
10.25.1 Yunnan Biopharmaceutical Co. Basic Information
10.25.2 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Overview
10.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Market Performance
10.25.4 Yunnan Biopharmaceutical Co. Business Overview
10.25.5 Yunnan Biopharmaceutical Co. Recent Developments
10.26 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd.
10.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Basic Information
10.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Business Overview
10.26.5 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Recent Developments
10.27 Liaoning Yikang Biological Co.Ltd.
10.27.1 Liaoning Yikang Biological Co.Ltd. Basic Information
10.27.2 Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.27.3 Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.27.4 Liaoning Yikang Biological Co.Ltd. Business Overview
10.27.5 Liaoning Yikang Biological Co.Ltd. Recent Developments
10.28 Shanghui Huahong Biological Engineering Co.Ltd.
10.28.1 Shanghui Huahong Biological Engineering Co.Ltd. Basic Information
10.28.2 Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.28.3 Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.28.4 Shanghui Huahong Biological Engineering Co.Ltd. Business Overview
10.28.5 Shanghui Huahong Biological Engineering Co.Ltd. Recent Developments
10.29 Sichuan Hailinge Biological Pharmaceutical Co.Ltd.
10.29.1 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Basic Information
10.29.2 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.29.3 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.29.4 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Business Overview
10.29.5 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Recent Developments
10.30 Guangdong Yongshun Biological Pharmaceutical Co.Ltd.
10.30.1 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Basic Information
10.30.2 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.30.3 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.30.4 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Business Overview
10.30.5 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Recent Developments
11 PSEUDORABIES VIRUS VACCINE MARKET FORECAST BY REGION
11.1 Global Pseudorabies Virus Vaccine Market Size Forecast
11.2 Global Pseudorabies Virus Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pseudorabies Virus Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pseudorabies Virus Vaccine Market Size Forecast by Region
11.2.4 South America Pseudorabies Virus Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pseudorabies Virus Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Pseudorabies Virus Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Pseudorabies Virus Vaccine by Type (2026-2033)
12.1.2 Global Pseudorabies Virus Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Pseudorabies Virus Vaccine by Type (2026-2033)
12.2 Global Pseudorabies Virus Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Pseudorabies Virus Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pseudorabies Virus Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pseudorabies Virus Vaccine
1.2 Key Market Segments
1.2.1 Pseudorabies Virus Vaccine Segment by Type
1.2.2 Pseudorabies Virus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PSEUDORABIES VIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pseudorabies Virus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Pseudorabies Virus Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PSEUDORABIES VIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pseudorabies Virus Vaccine Product Life Cycle
3.3 Global Pseudorabies Virus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pseudorabies Virus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pseudorabies Virus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pseudorabies Virus Vaccine Market Competitive Situation and Trends
3.8.1 Pseudorabies Virus Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pseudorabies Virus Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PSEUDORABIES VIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pseudorabies Virus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PSEUDORABIES VIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pseudorabies Virus Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pseudorabies Virus Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PSEUDORABIES VIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pseudorabies Virus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pseudorabies Virus Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Pseudorabies Virus Vaccine Price by Type (2020-2025)
7 PSEUDORABIES VIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pseudorabies Virus Vaccine Market Sales by Application (2020-2025)
7.3 Global Pseudorabies Virus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pseudorabies Virus Vaccine Sales Growth Rate by Application (2020-2025)
8 PSEUDORABIES VIRUS VACCINE MARKET SALES BY REGION
8.1 Global Pseudorabies Virus Vaccine Sales by Region
8.1.1 Global Pseudorabies Virus Vaccine Sales by Region
8.1.2 Global Pseudorabies Virus Vaccine Sales Market Share by Region
8.2 Global Pseudorabies Virus Vaccine Market Size by Region
8.2.1 Global Pseudorabies Virus Vaccine Market Size by Region
8.2.2 Global Pseudorabies Virus Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Pseudorabies Virus Vaccine Sales by Country
8.3.2 North America Pseudorabies Virus Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pseudorabies Virus Vaccine Sales by Country
8.4.2 Europe Pseudorabies Virus Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pseudorabies Virus Vaccine Sales by Region
8.5.2 Asia Pacific Pseudorabies Virus Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pseudorabies Virus Vaccine Sales by Country
8.6.2 South America Pseudorabies Virus Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pseudorabies Virus Vaccine Sales by Region
8.7.2 Middle East and Africa Pseudorabies Virus Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PSEUDORABIES VIRUS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pseudorabies Virus Vaccine by Region(2020-2025)
9.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pseudorabies Virus Vaccine Production
9.4.1 North America Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pseudorabies Virus Vaccine Production
9.5.1 Europe Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pseudorabies Virus Vaccine Production (2020-2025)
9.6.1 Japan Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pseudorabies Virus Vaccine Production (2020-2025)
9.7.1 China Pseudorabies Virus Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pseudorabies Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Pseudorabies Virus Vaccine Product Overview
10.1.3 Merck Pseudorabies Virus Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Merial Limited
10.2.1 Merial Limited Basic Information
10.2.2 Merial Limited Pseudorabies Virus Vaccine Product Overview
10.2.3 Merial Limited Pseudorabies Virus Vaccine Product Market Performance
10.2.4 Merial Limited Business Overview
10.2.5 Merial Limited SWOT Analysis
10.2.6 Merial Limited Recent Developments
10.3 Boehringer Ingelheim Animal Health (USA) Co.Ltd.
10.3.1 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Basic Information
10.3.2 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.3.3 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.3.4 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Business Overview
10.3.5 Boehringer Ingelheim Animal Health (USA) Co.Ltd. SWOT Analysis
10.3.6 Boehringer Ingelheim Animal Health (USA) Co.Ltd. Recent Developments
10.4 Zoetis
10.4.1 Zoetis Basic Information
10.4.2 Zoetis Pseudorabies Virus Vaccine Product Overview
10.4.3 Zoetis Pseudorabies Virus Vaccine Product Market Performance
10.4.4 Zoetis Business Overview
10.4.5 Zoetis Recent Developments
10.5 Hipra
10.5.1 Hipra Basic Information
10.5.2 Hipra Pseudorabies Virus Vaccine Product Overview
10.5.3 Hipra Pseudorabies Virus Vaccine Product Market Performance
10.5.4 Hipra Business Overview
10.5.5 Hipra Recent Developments
10.6 Anhui Divinity Biological Products
10.6.1 Anhui Divinity Biological Products Basic Information
10.6.2 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Overview
10.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Market Performance
10.6.4 Anhui Divinity Biological Products Business Overview
10.6.5 Anhui Divinity Biological Products Recent Developments
10.7 Wuhan Keqian Biological Co.Ltd.
10.7.1 Wuhan Keqian Biological Co.Ltd. Basic Information
10.7.2 Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.7.3 Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.7.4 Wuhan Keqian Biological Co.Ltd. Business Overview
10.7.5 Wuhan Keqian Biological Co.Ltd. Recent Developments
10.8 China Biotechnology Co.Ltd.
10.8.1 China Biotechnology Co.Ltd. Basic Information
10.8.2 China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.8.3 China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.8.4 China Biotechnology Co.Ltd. Business Overview
10.8.5 China Biotechnology Co.Ltd. Recent Developments
10.9 CHINA ANIMAL HUSBANDRY INDUSTRY
10.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Basic Information
10.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Overview
10.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Market Performance
10.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Business Overview
10.9.5 CHINA ANIMAL HUSBANDRY INDUSTRY Recent Developments
10.10 Sichuan Huashen
10.10.1 Sichuan Huashen Basic Information
10.10.2 Sichuan Huashen Pseudorabies Virus Vaccine Product Overview
10.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Product Market Performance
10.10.4 Sichuan Huashen Business Overview
10.10.5 Sichuan Huashen Recent Developments
10.11 Haley
10.11.1 Haley Basic Information
10.11.2 Haley Pseudorabies Virus Vaccine Product Overview
10.11.3 Haley Pseudorabies Virus Vaccine Product Market Performance
10.11.4 Haley Business Overview
10.11.5 Haley Recent Developments
10.12 Tianbang
10.12.1 Tianbang Basic Information
10.12.2 Tianbang Pseudorabies Virus Vaccine Product Overview
10.12.3 Tianbang Pseudorabies Virus Vaccine Product Market Performance
10.12.4 Tianbang Business Overview
10.12.5 Tianbang Recent Developments
10.13 Dabei Nong
10.13.1 Dabei Nong Basic Information
10.13.2 Dabei Nong Pseudorabies Virus Vaccine Product Overview
10.13.3 Dabei Nong Pseudorabies Virus Vaccine Product Market Performance
10.13.4 Dabei Nong Business Overview
10.13.5 Dabei Nong Recent Developments
10.14 Harvey
10.14.1 Harvey Basic Information
10.14.2 Harvey Pseudorabies Virus Vaccine Product Overview
10.14.3 Harvey Pseudorabies Virus Vaccine Product Market Performance
10.14.4 Harvey Business Overview
10.14.5 Harvey Recent Developments
10.15 Preh Bio
10.15.1 Preh Bio Basic Information
10.15.2 Preh Bio Pseudorabies Virus Vaccine Product Overview
10.15.3 Preh Bio Pseudorabies Virus Vaccine Product Market Performance
10.15.4 Preh Bio Business Overview
10.15.5 Preh Bio Recent Developments
10.16 Jiangsu Nannong High-Tech Co.
10.16.1 Jiangsu Nannong High-Tech Co. Basic Information
10.16.2 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Overview
10.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Market Performance
10.16.4 Jiangsu Nannong High-Tech Co. Business Overview
10.16.5 Jiangsu Nannong High-Tech Co. Recent Developments
10.17 Guangxi Liyuan Biological Co.Ltd.
10.17.1 Guangxi Liyuan Biological Co.Ltd. Basic Information
10.17.2 Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.17.3 Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.17.4 Guangxi Liyuan Biological Co.Ltd. Business Overview
10.17.5 Guangxi Liyuan Biological Co.Ltd. Recent Developments
10.18 Jilin Zhengye Bioengineering Group
10.18.1 Jilin Zhengye Bioengineering Group Basic Information
10.18.2 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Overview
10.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Market Performance
10.18.4 Jilin Zhengye Bioengineering Group Business Overview
10.18.5 Jilin Zhengye Bioengineering Group Recent Developments
10.19 Jilin Heyuan Biological Engineering Co.Ltd.
10.19.1 Jilin Heyuan Biological Engineering Co.Ltd. Basic Information
10.19.2 Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.19.3 Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.19.4 Jilin Heyuan Biological Engineering Co.Ltd. Business Overview
10.19.5 Jilin Heyuan Biological Engineering Co.Ltd. Recent Developments
10.20 Huapai Biological Engineering Group Co.Ltd.
10.20.1 Huapai Biological Engineering Group Co.Ltd. Basic Information
10.20.2 Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.20.3 Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.20.4 Huapai Biological Engineering Group Co.Ltd. Business Overview
10.20.5 Huapai Biological Engineering Group Co.Ltd. Recent Developments
10.21 Beijing Xinde Weite Technology Co.Ltd.
10.21.1 Beijing Xinde Weite Technology Co.Ltd. Basic Information
10.21.2 Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.21.3 Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.21.4 Beijing Xinde Weite Technology Co.Ltd. Business Overview
10.21.5 Beijing Xinde Weite Technology Co.Ltd. Recent Developments
10.22 Beijing Veterinary Biopharmaceutical Factory
10.22.1 Beijing Veterinary Biopharmaceutical Factory Basic Information
10.22.2 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Overview
10.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Market Performance
10.22.4 Beijing Veterinary Biopharmaceutical Factory Business Overview
10.22.5 Beijing Veterinary Biopharmaceutical Factory Recent Developments
10.23 Qilu Animal Health Products Co.Ltd.
10.23.1 Qilu Animal Health Products Co.Ltd. Basic Information
10.23.2 Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.23.3 Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.23.4 Qilu Animal Health Products Co.Ltd. Business Overview
10.23.5 Qilu Animal Health Products Co.Ltd. Recent Developments
10.24 Shanxi Longkel Bio-Pharmaceutical Co.Ltd.
10.24.1 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Basic Information
10.24.2 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.24.3 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.24.4 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Business Overview
10.24.5 Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Recent Developments
10.25 Yunnan Biopharmaceutical Co.
10.25.1 Yunnan Biopharmaceutical Co. Basic Information
10.25.2 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Overview
10.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Market Performance
10.25.4 Yunnan Biopharmaceutical Co. Business Overview
10.25.5 Yunnan Biopharmaceutical Co. Recent Developments
10.26 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd.
10.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Basic Information
10.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Business Overview
10.26.5 Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Recent Developments
10.27 Liaoning Yikang Biological Co.Ltd.
10.27.1 Liaoning Yikang Biological Co.Ltd. Basic Information
10.27.2 Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.27.3 Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.27.4 Liaoning Yikang Biological Co.Ltd. Business Overview
10.27.5 Liaoning Yikang Biological Co.Ltd. Recent Developments
10.28 Shanghui Huahong Biological Engineering Co.Ltd.
10.28.1 Shanghui Huahong Biological Engineering Co.Ltd. Basic Information
10.28.2 Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.28.3 Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.28.4 Shanghui Huahong Biological Engineering Co.Ltd. Business Overview
10.28.5 Shanghui Huahong Biological Engineering Co.Ltd. Recent Developments
10.29 Sichuan Hailinge Biological Pharmaceutical Co.Ltd.
10.29.1 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Basic Information
10.29.2 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.29.3 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.29.4 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Business Overview
10.29.5 Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Recent Developments
10.30 Guangdong Yongshun Biological Pharmaceutical Co.Ltd.
10.30.1 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Basic Information
10.30.2 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
10.30.3 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Market Performance
10.30.4 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Business Overview
10.30.5 Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Recent Developments
11 PSEUDORABIES VIRUS VACCINE MARKET FORECAST BY REGION
11.1 Global Pseudorabies Virus Vaccine Market Size Forecast
11.2 Global Pseudorabies Virus Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pseudorabies Virus Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pseudorabies Virus Vaccine Market Size Forecast by Region
11.2.4 South America Pseudorabies Virus Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pseudorabies Virus Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Pseudorabies Virus Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Pseudorabies Virus Vaccine by Type (2026-2033)
12.1.2 Global Pseudorabies Virus Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Pseudorabies Virus Vaccine by Type (2026-2033)
12.2 Global Pseudorabies Virus Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Pseudorabies Virus Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pseudorabies Virus Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pseudorabies Virus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Pseudorabies Virus Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Pseudorabies Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pseudorabies Virus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Pseudorabies Virus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudorabies Virus Vaccine as of 2024)
Table 10. Global Market Pseudorabies Virus Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Pseudorabies Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Pseudorabies Virus Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Pseudorabies Virus Vaccine Sales by Type (K MT)
Table 26. Global Pseudorabies Virus Vaccine Market Size by Type (M USD)
Table 27. Global Pseudorabies Virus Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Pseudorabies Virus Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Pseudorabies Virus Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Pseudorabies Virus Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Pseudorabies Virus Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Pseudorabies Virus Vaccine Sales (K MT) by Application
Table 33. Global Pseudorabies Virus Vaccine Market Size by Application
Table 34. Global Pseudorabies Virus Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Pseudorabies Virus Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Pseudorabies Virus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Pseudorabies Virus Vaccine Market Share by Application (2020-2025)
Table 38. Global Pseudorabies Virus Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Pseudorabies Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Pseudorabies Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Pseudorabies Virus Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Pseudorabies Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Pseudorabies Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Pseudorabies Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Pseudorabies Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Pseudorabies Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Pseudorabies Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Pseudorabies Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Pseudorabies Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Pseudorabies Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Pseudorabies Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Pseudorabies Virus Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Pseudorabies Virus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Pseudorabies Virus Vaccine Product Overview
Table 63. Merck Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Merial Limited Basic Information
Table 68. Merial Limited Pseudorabies Virus Vaccine Product Overview
Table 69. Merial Limited Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Merial Limited Business Overview
Table 71. Merial Limited SWOT Analysis
Table 72. Merial Limited Recent Developments
Table 73. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Basic Information
Table 74. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 75. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Business Overview
Table 77. Boehringer Ingelheim Animal Health (USA) Co.Ltd. SWOT Analysis
Table 78. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Recent Developments
Table 79. Zoetis Basic Information
Table 80. Zoetis Pseudorabies Virus Vaccine Product Overview
Table 81. Zoetis Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Zoetis Business Overview
Table 83. Zoetis Recent Developments
Table 84. Hipra Basic Information
Table 85. Hipra Pseudorabies Virus Vaccine Product Overview
Table 86. Hipra Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Hipra Business Overview
Table 88. Hipra Recent Developments
Table 89. Anhui Divinity Biological Products Basic Information
Table 90. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Overview
Table 91. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Anhui Divinity Biological Products Business Overview
Table 93. Anhui Divinity Biological Products Recent Developments
Table 94. Wuhan Keqian Biological Co.Ltd. Basic Information
Table 95. Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 96. Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Wuhan Keqian Biological Co.Ltd. Business Overview
Table 98. Wuhan Keqian Biological Co.Ltd. Recent Developments
Table 99. China Biotechnology Co.Ltd. Basic Information
Table 100. China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 101. China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. China Biotechnology Co.Ltd. Business Overview
Table 103. China Biotechnology Co.Ltd. Recent Developments
Table 104. CHINA ANIMAL HUSBANDRY INDUSTRY Basic Information
Table 105. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Overview
Table 106. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. CHINA ANIMAL HUSBANDRY INDUSTRY Business Overview
Table 108. CHINA ANIMAL HUSBANDRY INDUSTRY Recent Developments
Table 109. Sichuan Huashen Basic Information
Table 110. Sichuan Huashen Pseudorabies Virus Vaccine Product Overview
Table 111. Sichuan Huashen Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Sichuan Huashen Business Overview
Table 113. Sichuan Huashen Recent Developments
Table 114. Haley Basic Information
Table 115. Haley Pseudorabies Virus Vaccine Product Overview
Table 116. Haley Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Haley Business Overview
Table 118. Haley Recent Developments
Table 119. Tianbang Basic Information
Table 120. Tianbang Pseudorabies Virus Vaccine Product Overview
Table 121. Tianbang Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Tianbang Business Overview
Table 123. Tianbang Recent Developments
Table 124. Dabei Nong Basic Information
Table 125. Dabei Nong Pseudorabies Virus Vaccine Product Overview
Table 126. Dabei Nong Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Dabei Nong Business Overview
Table 128. Dabei Nong Recent Developments
Table 129. Harvey Basic Information
Table 130. Harvey Pseudorabies Virus Vaccine Product Overview
Table 131. Harvey Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Harvey Business Overview
Table 133. Harvey Recent Developments
Table 134. Preh Bio Basic Information
Table 135. Preh Bio Pseudorabies Virus Vaccine Product Overview
Table 136. Preh Bio Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Preh Bio Business Overview
Table 138. Preh Bio Recent Developments
Table 139. Jiangsu Nannong High-Tech Co. Basic Information
Table 140. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Overview
Table 141. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Jiangsu Nannong High-Tech Co. Business Overview
Table 143. Jiangsu Nannong High-Tech Co. Recent Developments
Table 144. Guangxi Liyuan Biological Co.Ltd. Basic Information
Table 145. Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 146. Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Guangxi Liyuan Biological Co.Ltd. Business Overview
Table 148. Guangxi Liyuan Biological Co.Ltd. Recent Developments
Table 149. Jilin Zhengye Bioengineering Group Basic Information
Table 150. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Overview
Table 151. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Jilin Zhengye Bioengineering Group Business Overview
Table 153. Jilin Zhengye Bioengineering Group Recent Developments
Table 154. Jilin Heyuan Biological Engineering Co.Ltd. Basic Information
Table 155. Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 156. Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Jilin Heyuan Biological Engineering Co.Ltd. Business Overview
Table 158. Jilin Heyuan Biological Engineering Co.Ltd. Recent Developments
Table 159. Huapai Biological Engineering Group Co.Ltd. Basic Information
Table 160. Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 161. Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. Huapai Biological Engineering Group Co.Ltd. Business Overview
Table 163. Huapai Biological Engineering Group Co.Ltd. Recent Developments
Table 164. Beijing Xinde Weite Technology Co.Ltd. Basic Information
Table 165. Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 166. Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. Beijing Xinde Weite Technology Co.Ltd. Business Overview
Table 168. Beijing Xinde Weite Technology Co.Ltd. Recent Developments
Table 169. Beijing Veterinary Biopharmaceutical Factory Basic Information
Table 170. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Overview
Table 171. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 172. Beijing Veterinary Biopharmaceutical Factory Business Overview
Table 173. Beijing Veterinary Biopharmaceutical Factory Recent Developments
Table 174. Qilu Animal Health Products Co.Ltd. Basic Information
Table 175. Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 176. Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 177. Qilu Animal Health Products Co.Ltd. Business Overview
Table 178. Qilu Animal Health Products Co.Ltd. Recent Developments
Table 179. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Basic Information
Table 180. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 181. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 182. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Business Overview
Table 183. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Recent Developments
Table 184. Yunnan Biopharmaceutical Co. Basic Information
Table 185. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Overview
Table 186. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 187. Yunnan Biopharmaceutical Co. Business Overview
Table 188. Yunnan Biopharmaceutical Co. Recent Developments
Table 189. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Basic Information
Table 190. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 191. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 192. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Business Overview
Table 193. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Recent Developments
Table 194. Liaoning Yikang Biological Co.Ltd. Basic Information
Table 195. Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 196. Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 197. Liaoning Yikang Biological Co.Ltd. Business Overview
Table 198. Liaoning Yikang Biological Co.Ltd. Recent Developments
Table 199. Shanghui Huahong Biological Engineering Co.Ltd. Basic Information
Table 200. Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 201. Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 202. Shanghui Huahong Biological Engineering Co.Ltd. Business Overview
Table 203. Shanghui Huahong Biological Engineering Co.Ltd. Recent Developments
Table 204. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Basic Information
Table 205. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 206. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 207. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Business Overview
Table 208. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Recent Developments
Table 209. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Basic Information
Table 210. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 211. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 212. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Business Overview
Table 213. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Recent Developments
Table 214. Global Pseudorabies Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 215. Global Pseudorabies Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 216. North America Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 217. North America Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 218. Europe Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 219. Europe Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 220. Asia Pacific Pseudorabies Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 221. Asia Pacific Pseudorabies Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 222. South America Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 223. South America Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 224. Middle East and Africa Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 225. Middle East and Africa Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 226. Global Pseudorabies Virus Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 227. Global Pseudorabies Virus Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 228. Global Pseudorabies Virus Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 229. Global Pseudorabies Virus Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 230. Global Pseudorabies Virus Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pseudorabies Virus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Pseudorabies Virus Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Pseudorabies Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pseudorabies Virus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Pseudorabies Virus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudorabies Virus Vaccine as of 2024)
Table 10. Global Market Pseudorabies Virus Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Pseudorabies Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Pseudorabies Virus Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Pseudorabies Virus Vaccine Sales by Type (K MT)
Table 26. Global Pseudorabies Virus Vaccine Market Size by Type (M USD)
Table 27. Global Pseudorabies Virus Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Pseudorabies Virus Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Pseudorabies Virus Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Pseudorabies Virus Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Pseudorabies Virus Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Pseudorabies Virus Vaccine Sales (K MT) by Application
Table 33. Global Pseudorabies Virus Vaccine Market Size by Application
Table 34. Global Pseudorabies Virus Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Pseudorabies Virus Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Pseudorabies Virus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Pseudorabies Virus Vaccine Market Share by Application (2020-2025)
Table 38. Global Pseudorabies Virus Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Pseudorabies Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Pseudorabies Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Pseudorabies Virus Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Pseudorabies Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Pseudorabies Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Pseudorabies Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Pseudorabies Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Pseudorabies Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Pseudorabies Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Pseudorabies Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Pseudorabies Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Pseudorabies Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Pseudorabies Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Pseudorabies Virus Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Pseudorabies Virus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Pseudorabies Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Pseudorabies Virus Vaccine Product Overview
Table 63. Merck Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Merial Limited Basic Information
Table 68. Merial Limited Pseudorabies Virus Vaccine Product Overview
Table 69. Merial Limited Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Merial Limited Business Overview
Table 71. Merial Limited SWOT Analysis
Table 72. Merial Limited Recent Developments
Table 73. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Basic Information
Table 74. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 75. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Business Overview
Table 77. Boehringer Ingelheim Animal Health (USA) Co.Ltd. SWOT Analysis
Table 78. Boehringer Ingelheim Animal Health (USA) Co.Ltd. Recent Developments
Table 79. Zoetis Basic Information
Table 80. Zoetis Pseudorabies Virus Vaccine Product Overview
Table 81. Zoetis Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Zoetis Business Overview
Table 83. Zoetis Recent Developments
Table 84. Hipra Basic Information
Table 85. Hipra Pseudorabies Virus Vaccine Product Overview
Table 86. Hipra Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Hipra Business Overview
Table 88. Hipra Recent Developments
Table 89. Anhui Divinity Biological Products Basic Information
Table 90. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Overview
Table 91. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Anhui Divinity Biological Products Business Overview
Table 93. Anhui Divinity Biological Products Recent Developments
Table 94. Wuhan Keqian Biological Co.Ltd. Basic Information
Table 95. Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 96. Wuhan Keqian Biological Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Wuhan Keqian Biological Co.Ltd. Business Overview
Table 98. Wuhan Keqian Biological Co.Ltd. Recent Developments
Table 99. China Biotechnology Co.Ltd. Basic Information
Table 100. China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 101. China Biotechnology Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. China Biotechnology Co.Ltd. Business Overview
Table 103. China Biotechnology Co.Ltd. Recent Developments
Table 104. CHINA ANIMAL HUSBANDRY INDUSTRY Basic Information
Table 105. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Overview
Table 106. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. CHINA ANIMAL HUSBANDRY INDUSTRY Business Overview
Table 108. CHINA ANIMAL HUSBANDRY INDUSTRY Recent Developments
Table 109. Sichuan Huashen Basic Information
Table 110. Sichuan Huashen Pseudorabies Virus Vaccine Product Overview
Table 111. Sichuan Huashen Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Sichuan Huashen Business Overview
Table 113. Sichuan Huashen Recent Developments
Table 114. Haley Basic Information
Table 115. Haley Pseudorabies Virus Vaccine Product Overview
Table 116. Haley Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Haley Business Overview
Table 118. Haley Recent Developments
Table 119. Tianbang Basic Information
Table 120. Tianbang Pseudorabies Virus Vaccine Product Overview
Table 121. Tianbang Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Tianbang Business Overview
Table 123. Tianbang Recent Developments
Table 124. Dabei Nong Basic Information
Table 125. Dabei Nong Pseudorabies Virus Vaccine Product Overview
Table 126. Dabei Nong Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Dabei Nong Business Overview
Table 128. Dabei Nong Recent Developments
Table 129. Harvey Basic Information
Table 130. Harvey Pseudorabies Virus Vaccine Product Overview
Table 131. Harvey Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Harvey Business Overview
Table 133. Harvey Recent Developments
Table 134. Preh Bio Basic Information
Table 135. Preh Bio Pseudorabies Virus Vaccine Product Overview
Table 136. Preh Bio Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Preh Bio Business Overview
Table 138. Preh Bio Recent Developments
Table 139. Jiangsu Nannong High-Tech Co. Basic Information
Table 140. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Overview
Table 141. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Jiangsu Nannong High-Tech Co. Business Overview
Table 143. Jiangsu Nannong High-Tech Co. Recent Developments
Table 144. Guangxi Liyuan Biological Co.Ltd. Basic Information
Table 145. Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 146. Guangxi Liyuan Biological Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Guangxi Liyuan Biological Co.Ltd. Business Overview
Table 148. Guangxi Liyuan Biological Co.Ltd. Recent Developments
Table 149. Jilin Zhengye Bioengineering Group Basic Information
Table 150. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Overview
Table 151. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Jilin Zhengye Bioengineering Group Business Overview
Table 153. Jilin Zhengye Bioengineering Group Recent Developments
Table 154. Jilin Heyuan Biological Engineering Co.Ltd. Basic Information
Table 155. Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 156. Jilin Heyuan Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Jilin Heyuan Biological Engineering Co.Ltd. Business Overview
Table 158. Jilin Heyuan Biological Engineering Co.Ltd. Recent Developments
Table 159. Huapai Biological Engineering Group Co.Ltd. Basic Information
Table 160. Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 161. Huapai Biological Engineering Group Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. Huapai Biological Engineering Group Co.Ltd. Business Overview
Table 163. Huapai Biological Engineering Group Co.Ltd. Recent Developments
Table 164. Beijing Xinde Weite Technology Co.Ltd. Basic Information
Table 165. Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 166. Beijing Xinde Weite Technology Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. Beijing Xinde Weite Technology Co.Ltd. Business Overview
Table 168. Beijing Xinde Weite Technology Co.Ltd. Recent Developments
Table 169. Beijing Veterinary Biopharmaceutical Factory Basic Information
Table 170. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Overview
Table 171. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 172. Beijing Veterinary Biopharmaceutical Factory Business Overview
Table 173. Beijing Veterinary Biopharmaceutical Factory Recent Developments
Table 174. Qilu Animal Health Products Co.Ltd. Basic Information
Table 175. Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 176. Qilu Animal Health Products Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 177. Qilu Animal Health Products Co.Ltd. Business Overview
Table 178. Qilu Animal Health Products Co.Ltd. Recent Developments
Table 179. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Basic Information
Table 180. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 181. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 182. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Business Overview
Table 183. Shanxi Longkel Bio-Pharmaceutical Co.Ltd. Recent Developments
Table 184. Yunnan Biopharmaceutical Co. Basic Information
Table 185. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Overview
Table 186. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 187. Yunnan Biopharmaceutical Co. Business Overview
Table 188. Yunnan Biopharmaceutical Co. Recent Developments
Table 189. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Basic Information
Table 190. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 191. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 192. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Business Overview
Table 193. Jiujiang Bomeilai Biological Pharmaceutical Co.Ltd. Recent Developments
Table 194. Liaoning Yikang Biological Co.Ltd. Basic Information
Table 195. Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 196. Liaoning Yikang Biological Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 197. Liaoning Yikang Biological Co.Ltd. Business Overview
Table 198. Liaoning Yikang Biological Co.Ltd. Recent Developments
Table 199. Shanghui Huahong Biological Engineering Co.Ltd. Basic Information
Table 200. Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 201. Shanghui Huahong Biological Engineering Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 202. Shanghui Huahong Biological Engineering Co.Ltd. Business Overview
Table 203. Shanghui Huahong Biological Engineering Co.Ltd. Recent Developments
Table 204. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Basic Information
Table 205. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 206. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 207. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Business Overview
Table 208. Sichuan Hailinge Biological Pharmaceutical Co.Ltd. Recent Developments
Table 209. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Basic Information
Table 210. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Product Overview
Table 211. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Pseudorabies Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 212. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Business Overview
Table 213. Guangdong Yongshun Biological Pharmaceutical Co.Ltd. Recent Developments
Table 214. Global Pseudorabies Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 215. Global Pseudorabies Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 216. North America Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 217. North America Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 218. Europe Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 219. Europe Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 220. Asia Pacific Pseudorabies Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 221. Asia Pacific Pseudorabies Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 222. South America Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 223. South America Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 224. Middle East and Africa Pseudorabies Virus Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 225. Middle East and Africa Pseudorabies Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 226. Global Pseudorabies Virus Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 227. Global Pseudorabies Virus Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 228. Global Pseudorabies Virus Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 229. Global Pseudorabies Virus Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 230. Global Pseudorabies Virus Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pseudorabies Virus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pseudorabies Virus Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Pseudorabies Virus Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Pseudorabies Virus Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pseudorabies Virus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pseudorabies Virus Vaccine Product Life Cycle
Figure 13. Pseudorabies Virus Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Pseudorabies Virus Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pseudorabies Virus Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pseudorabies Virus Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Pseudorabies Virus Vaccine
Figure 19. Global Pseudorabies Virus Vaccine Market PEST Analysis
Figure 20. Global Pseudorabies Virus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pseudorabies Virus Vaccine Market Share by Type
Figure 27. Sales Market Share of Pseudorabies Virus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pseudorabies Virus Vaccine by Type in 2024
Figure 29. Market Size Share of Pseudorabies Virus Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Pseudorabies Virus Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pseudorabies Virus Vaccine Market Share by Application
Figure 33. Global Pseudorabies Virus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pseudorabies Virus Vaccine Sales Market Share by Application in 2024
Figure 35. Global Pseudorabies Virus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pseudorabies Virus Vaccine Market Share by Application in 2024
Figure 37. Global Pseudorabies Virus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pseudorabies Virus Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pseudorabies Virus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pseudorabies Virus Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pseudorabies Virus Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pseudorabies Virus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pseudorabies Virus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pseudorabies Virus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pseudorabies Virus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pseudorabies Virus Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pseudorabies Virus Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pseudorabies Virus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pseudorabies Virus Vaccine Market Size Market Share by Region in 2024
Figure 68. China Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pseudorabies Virus Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pseudorabies Virus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pseudorabies Virus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pseudorabies Virus Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pseudorabies Virus Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pseudorabies Virus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pseudorabies Virus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pseudorabies Virus Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pseudorabies Virus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pseudorabies Virus Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Pseudorabies Virus Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Pseudorabies Virus Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Pseudorabies Virus Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Pseudorabies Virus Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Pseudorabies Virus Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Pseudorabies Virus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pseudorabies Virus Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Pseudorabies Virus Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Pseudorabies Virus Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pseudorabies Virus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pseudorabies Virus Vaccine Product Life Cycle
Figure 13. Pseudorabies Virus Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Pseudorabies Virus Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pseudorabies Virus Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pseudorabies Virus Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Pseudorabies Virus Vaccine
Figure 19. Global Pseudorabies Virus Vaccine Market PEST Analysis
Figure 20. Global Pseudorabies Virus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pseudorabies Virus Vaccine Market Share by Type
Figure 27. Sales Market Share of Pseudorabies Virus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pseudorabies Virus Vaccine by Type in 2024
Figure 29. Market Size Share of Pseudorabies Virus Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Pseudorabies Virus Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pseudorabies Virus Vaccine Market Share by Application
Figure 33. Global Pseudorabies Virus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pseudorabies Virus Vaccine Sales Market Share by Application in 2024
Figure 35. Global Pseudorabies Virus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pseudorabies Virus Vaccine Market Share by Application in 2024
Figure 37. Global Pseudorabies Virus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pseudorabies Virus Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pseudorabies Virus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pseudorabies Virus Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pseudorabies Virus Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pseudorabies Virus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pseudorabies Virus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pseudorabies Virus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pseudorabies Virus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pseudorabies Virus Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pseudorabies Virus Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pseudorabies Virus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pseudorabies Virus Vaccine Market Size Market Share by Region in 2024
Figure 68. China Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pseudorabies Virus Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pseudorabies Virus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pseudorabies Virus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pseudorabies Virus Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pseudorabies Virus Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pseudorabies Virus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pseudorabies Virus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pseudorabies Virus Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pseudorabies Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pseudorabies Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pseudorabies Virus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pseudorabies Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pseudorabies Virus Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Pseudorabies Virus Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Pseudorabies Virus Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Pseudorabies Virus Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Pseudorabies Virus Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Pseudorabies Virus Vaccine Market Share Forecast by Application (2026-2033)
